Circulating tumor cell (CTC) PD-L1 and interferon regulatory factor-1 (IRF-1) expression as biomarkers of anti-PD-(L)1 response.

Kennedy, L; Ramirez, AB; U'Ren, L; Sun, Y; Durenberger, G; Chow, LQM; Grivas, P; Gadi, VK

JOURNAL OF CLINICAL ONCOLOGY, 2019; 37 (15):